Parsaclisib Uses, Dosage, Side Effects and more
Parsaclisib is under investigation in clinical trial NCT03126019 (An Open-Label Study of Parsaclisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)).
| Attribute | Details |
|---|---|
| Trade Name | Parsaclisib |
| Generic | Parsaclisib |
| Parsaclisib Other Names | INCB050465, Parsaclisib |
| Type | |
| Formula | C20H22ClFN6O2 |
| Weight | Average: 432.88 Monoisotopic: 432.1476798 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
